Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d): Difference between revisions

From GxPlex

Jump to: navigation, search
← Older editNewer edit β†’
gxplex>GxPlexBot
Import from GxPlex Excel
Migrate to Template:ReferenceData for PageForms (GxPlexBot)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|has_document=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|RefScope=HM
|module=2
|RefDocPart=Article 15
|unit=2.3.3
|scope=HM
|doc_part=Article 15
(5) (d)
(5) (d)
|RefLanguage=EN
|language=EN
|RefTags=TAG-00134-Eth-kom ++ TAG-00018-Inv-die ++ TAG-00257-Sit-zen
|entry_by=Florian Adragna
|RefModule=2
|contributors=
|RefUnit=2.3.3
|tags=TAG-00134-Eth-kom ++ TAG-00018-Inv-die ++ TAG-00257-Sit-zen
}}
|tags_display=[[Glossary:TAG-00134-Eth-kom|Ethics committee]], [[Glossary:TAG-00018-Inv-die|Investigator]], [[Glossary:TAG-00257-Sit-zen|Site staff]]
Β 
|comment=Ethics committee opinion: considerations and criteria
{{:Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004}}
|content=Ethics committee opinion
Β 
{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 2 β€” Unit 2.3.3
|-
! Scope
| HM
|-
! Document part
| Article 15
(5) (d)
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00134-Eth-kom|Ethics committee]], [[Glossary:TAG-00018-Inv-die|Investigator]], [[Glossary:TAG-00257-Sit-zen|Site staff]]
|-
! Comment
| Ethics committee opinion: considerations and criteria
|}
Β 
== Content ==
Ethics committee opinion
15.β€” [...] Β 
15.β€” [...] Β 
(5) In preparing its opinion, the committee shall consider, in particular, the following mattersβ€”
(5) In preparing its opinion, the committee shall consider, in particular, the following mattersβ€”


(d)the suitability of the investigator and supporting staff;
(d)the suitability of the investigator and supporting staff;
}}

Revision as of 12:55, 16 July 2026



Document information
Reference GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
Validity area GBR
Scope(s) HM
Document name The Medicines for Human Use (Clinical Trials) Regulations 2004
Version / Revision 01-May-2004
Status Current
Document type Legal act
Language(s) EN
Description The Medicines for Human Use (Clinical Trials) Regulations 2004
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 β€” Unit 2.3.3
Scope HM
Document part Article 15

(5) (d)

Language EN
Original entry by Florian Adragna
Contributors
Tags Ethics committee, Investigator, Site staff

Content

Ethics committee opinion 15.β€” [...] (5) In preparing its opinion, the committee shall consider, in particular, the following mattersβ€”

(d)the suitability of the investigator and supporting staff;

Retrieved from "https://gxplex.org/index.php?title=Reference:GBR_The_Medicines_for_Human_Use_(Clinical_Trials)_Regulations_2004_01-May-2004_Article_15_(5)_(d)&oldid=16449"